United Therapeutics Corp (NASDAQ:UTHR)

117.49
Delayed Data
As of Jun 19
 +1.93 / +1.67%
Today’s Change
100.57
Today|||52-Week Range
152.55
-20.59%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2014

2015

2016

2017
Revenue and IncomeNet Revenues1.3B1.5B1.6B1.7B
 
 
 
 
 
Cost of Goods Sold93.6M36.1M41.1M74.7M
 
 
 
 
 
Depreciation And Amortization32.2M32.9M31.6M31.0M
 
 
 
 
 
 
Operating ExpensesGross Income1.2B1.4B1.5B1.6B
 
 
 
 
 
General Expenses623.8M697.7M464.4M594.7M
 
 
 
 
 
Research And Development242.5M245.1M147.6M264.6M
 
 
 
 
 
Total Operating Expenses749.7M766.7M537.1M700.4M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income538.8M699.0M1.1B1.0B
 
 
 
 
 
Extraordinary Charge-1.1M0.000.00-259.6M
 
 
 
Interest Expense On Debt17.6M4.7M3.9M9.0M
 
 
 
 
 
Other Expenses5.1M350.2M2.4M13.2M
 
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income525.2M1.0B1.1B769.5M
 
 
 
 
 
Income Taxes-185.1M-392.8M-346.5M-351.6M
 
 
 
 
 
Net Income340.1M651.6M713.7M417.9M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS48.2M46.0M43.8M44.0M
 
 
 
 
 
Shares To Calculate EPS Diluted54.2M51.2M46.8M44.9M
 
 
 
 
 
 
Earnings Per ShareEPS$6.28$12.72$15.25$9.31
 
 
 
 
 
EPS Diluted$6.28$12.72$15.25$9.31